Monteris Medical announced today that its NeuroBlate® System, currently the only minimally invasive robotic laser thermotherapy tool available in Canada, has been used for the first time following Health Canada Licensing late last year. Brian D. Toyota, MD CM MSc FRCSC, head of the division of neurosurgery, The University of British Columbia, performed the first NeuroBlate procedure at Vancouver General Hospital.
Dr. Toyota used the NeuroBlate System’s magnetic resonance imaging (MRI) and software-based visualization to ablate a tumor in 22-year-old Eric Dorchester’s brain. Mr. Dorchester has undergone multiple surgeries and chemotherapy for osteosarcoma, a cancerous bone tumor that usually develops in teenagers.
“With NeuroBlate, we aim to remove the diseased tissue while protecting the healthy tissue around it as much as possible. In some situations we can remove the vast majority of the tumor, with a minimally invasive procedure that may allow the patient to even walk out of the hospital in about 24 hours,” said Dr. Toyota. “I am proud to be the first surgeon in Canada to use this technology, but even more I am especially pleased with how well it worked for Eric. He was in a dire situation, but the procedure went very well and his post-operative recovery was remarkable. I know he is looking forward to tackling more adventures in 2015.”
The NeuroBlate System employs a pulsed surgical laser to deliver targeted energy to abnormal brain tissue such as tumors and other neurological soft tissue lesions. With the NeuroBlate System, a surgeon makes a small hole in the skull, approximately as wide as a pencil. With precision, the surgeon then guides a small laser probe through the hole into the tumor. The probe delivers laser light energy to heat and destroy the tumor, through a process called ablation. The NeuroBlate System includes software that allows surgeons to precisely guide the ablation on a computer screen with MRI visualization.
With its minimally invasive and image-guided approach, the NeuroBlate System has shown results analogous to open surgery.1 However, because of its minimally-invasive nature, patients undergoing procedures with the NeuroBlate System may experience less pain and reduced hospital length of stay compared with those undergoing open surgical procedures.
“Monteris Medical congratulates Dr. Toyota for conducting the first NeuroBlate procedure in Canada while also sending our best wishes to Mr. Dorchester and his family," said John Schellhorn, President and CEO of Monteris Medical. “It is our hope that Canadian patients suffering from a variety of neuro pathologies will have access to a technology which enables them to have less traumatic neurosurgery experiences, with all of the benefits which that enables.”